DanielAlfredScottMD

PubMed

• 46 citations
  Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
  Brandon Essink, Charu Sabharwal, Kevin Cannon, Robert Frenck, Himal Lal, Xia Xu, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Michael W Pride, Ingrid L Scully, Kathrin U...> ;Clinical Infectious Diseases. 2022 Aug 31
• 19 citations
  Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated ...
  Ann R Falsey, Edward E Walsh, Daniel A Scott, Alejandra Gurtman, Agnieszka Zareba, Kathrin U Jansen, William C Gruber, Philip R Dormitzer, Kena A Swanson, Qin Jiang, E...> ;The Journal of Infectious Diseases. 2022 Jun 15
• 12 citations
  A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
  Edward E Walsh, Ann R Falsey, Daniel A Scott, Alejandra Gurtman, Agnieszka M Zareba, Kathrin U Jansen, William C Gruber, Philip R Dormitzer, Kena A Swanson, David Radl...> ;The Journal of Infectious Diseases. 2022 Apr 19
• 12 citations
  Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Co-Administered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
  James T Peterson, Agnieszka M Zareba, David R. FitzPatrick, Brandon Essink, Daniel A. Scott, Kena A. Swanson, Dhawal Chelani, David Radley, David A. Cooper, Kathrin U....> ;The Journal of Infectious Diseases. 2021 Oct 12
• 23 citations
  Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States.
  Shelly Senders, Nicola P. Klein, Erik Lamberth, Allison Thompson, Jelena Drozd, James Trammel, Yahong Peng, Peter C. Giardina, Kathrin U. Jansen, William C. Gruber, Da...> ;The Pediatric Infectious Disease Journal. 2021 Oct 1
• 7 citations
  A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.
  David R. FitzPatrick, Mariano Young, Daniel A. Scott, Ingrid L. Scully, Gary Baugher, Yahong Peng, Kathrin U. Jansen, William C. Gruber, Wendy Watson> ;Human Vaccines & Immunotherapeutics. 2021 Feb 5
• 4 citations
  Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose.
  Ron Dagan, Qin Jiang, Christine Juergens, James Trammel, William C. Gruber, Daniel A. Scott> ;Clinical Infectious Diseases. 2021 Feb 1
• 46 citations
  Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, o...
  Judith Absalon, Nathan Segall, Stan L. Block, Ingrid L. Scully, Peter C. Giardina, James Peterson, Wendy Watson, William C. Gruber, Kathrin U. Jansen, Yahong Peng, Sam...> ;The Lancet. Infectious Diseases. 2021 Feb 1
• 87 citations
  Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
  Donald Hurley, Carl Griffin, Mariano Young, Daniel A. Scott, Michael W. Pride, Ingrid L. Scully, John Ginis, Joseph M. Severs, Kathrin U. Jansen, William C. Gruber, We...> ;Clinical Infectious Diseases. 2021 Oct 5
• 5 citations
  Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
  Erica Chilson, Daniel A. Scott, Beate Schmoele-Thoma, Wendy Watson, Mary M Moran, Raul E Isturiz> ;Human Vaccines & Immunotherapeutics. 2020 Jun 12
• 17 citations
  Diabetes mellitus as a vaccine-effect modifier: a review.
  Thomas Verstraeten, Mark A. Fletcher, Jose A Suaya, Sally Jackson, Cassandra Hall-Murray, Daniel A. Scott, Beate Schmöle-Thoma, Raul E Isturiz, Bradford D Gessner> ;Expert Review of Vaccines. 2020 Jun 9
• 11 citations
  Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
  Roger Baxter, Laurie Aukes, Stephen I. Pelton, Arnold Yee, Nicola P. Klein, William C. Gruber, Daniel A. Scott> ;Journal of the Pediatric Infectious Diseases Society. 2021 Mar 26
• 5 citations
  Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China.
  Fengcai Zhu, Hu Yuemei, Jingxin Li, Qiang Ye, Mariano M. Young, John Z. Liang, William C. Gruber, Peter C. Giardina, Daniel A. Scott> ;The Pediatric Infectious Disease Journal. 2019 Nov 1
• 78 citations
  Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
  Allison Thompson, Erik Lamberth, Joseph M. Severs, Ingrid L. Scully, Sanela Tarabar, John Ginis, Kathrin U. Jansen, William C. Gruber, Daniel A. Scott, Wendy Watson> ;Vaccine. 2019 Sep 30
• 40 citations
  A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.
  Bradford D Gessner, Qin Jiang, Cornelis H. van Werkhoven, Heather L Sings, Chris Webber, Daniel A. Scott, Kathleen M. Neuzil, Katherine L. O'Brien, Richard G. Wunderin...> ;Vaccine. 2019 Sep 10
• 25 citations
  A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized c...
  Bradford D Gessner, Qin Jiang, Cornelis H. van Werkhoven, Heather L Sings, Chris Webber, Daniel A. Scott, William C. Gruber, Diederick E. Grobbee, Marc J. M. Bonten, L...> ;Vaccine. 2019 Jul 9
• 16 citations
  National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States
  Xiaofeng Zhou, Cynthia de Luise, Michael Gaffney, Catharine W. Burt, Daniel A. Scott, Nicolle M. Gatto> ;International Journal of Pediatric Otorhinolaryngology. 2019 Apr 1
• 5 citations
  Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine ...
  Beate Schmoele-Thoma, Martin van Cleeff, Richard N. Greenberg, Alejandra Gurtman, Thomas R. Jones, Vani Sundaraiyer, William C. Gruber, Daniel A. Scott> ;Human Vaccines & Immunotherapeutics. 2019 Jan 16
• 12 citations
  Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal va...
  Allison Thompson, Nicola P. Klein, H. Jackson Downey, Scott Patterson, Vani Sundaraiyer, Wendy Watson, Keri Clarke, Kathrin U. Jansen, Shite Sebastian, William C. Grub...> ;Human Vaccines & Immunotherapeutics. 2019 Jan 1
• 6 citations
  Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population.
  Daina B. Esposito, Lina Titievsky, Daniel C. Beachler, Jennifer C.L. Hawes, Raul E Isturiz, Daniel A. Scott, Kelsey Gangemi, Robert Maroko, Cassandra Hall-Murray, Step...> ;Vaccine. 2018 Dec 18
• 17 citations
  Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides
  Charles Tan, Fred Immermann, Shite Sebastian, Michael W. Pride, Danka Pavliakova, Kelly A. Belanger, Wendy Watson, Daniel A. Scott, Mohinder Sidhu, Kathrin U. Jansen, ...> ;Msphere. 2018 Aug 8
• 55 citations
  Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a...
  Michael E. Pichichero, Ravinder Kaur, Daniel A. Scott, William C. Gruber, James Trammel, Anthony Almudevar> ;The Lancet. Child & Adolescent Health. 2018 Aug 1
• Tobacco-induced suppression of the vascular response to dental plaque.
  Buduneli, N.,Scott, D. A.> ;Mol Oral Microbiol. 2018 May 17
• 3 citations
  Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations
  Christine Juergens, James Trammel, Yasuko Shoji, Scott Patterson, Wendy Watson, Chris Webber, William C. Gruber, Daniel A. Scott, Beate Schmoele-Thoma> ;Human Vaccines & Immunotherapeutics. 2018 Apr 13
• 30 citations
  Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
  Jose A Suaya, Qin Jiang, Daniel A. Scott, William C. Gruber, Chris Webber, Beate Schmoele-Thoma, Cassandra Hall-Murray, Luis Jodar, Raul E Isturiz> ;Vaccine. 2018 Mar 7
• Join now to see all